PHP Code

Using the PHP code extracts allows Academic Staff Profiles to be displayed in a number of different styles including the tabbed format shown below - the data is provided dynamically from the IRIS application, while maintaning the consistent look and feel of your site.

Prof Perry Elliott

  • Telephone:

    0207 573 8888

  • Fax:

    0207 575 8838

  • Email:

    perry.elliott@ucl.ac.uk

  • Address:

    The Heart Hospital,
    London,
    W1G8PH

  • Appointments:

    Professor in Inherited Cardiovascular Disease, Centre for Cardiology in the Young, Institute of Cardiovascular Science

Research Activities

  • Paediatric Neurology
  • Pathophysiology of lysosomal storage disorders

Recent Publications

Displaying 50 most recent publications. For the full list please visit UCL Discovery

  1. Haywood AF,Merner ND,Hodgkinson KA,Houston J,Syrris P,Booth V,Connors S,Pantazis A,Quarta G,Elliott P,McKenna W,Young TL (2013) Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada. Eur Heart J, 34(13), 1002 - 1011. 10.1093/eurheartj/ehs383.
  2. Critoph CH,Patel V,Mist B,Thomas MD,Elliott PM (2013) Non-invasive assessment of cardiac output at rest and during exercise by finger plethysmography Clinical Physiology and Functional Imaging.
  3. Sado DM,White SK,Piechnik SK,Banypersad SM,Treibel T,Captur G,Fontana M,Maestrini V,Flett AS,Robson MD,Lachmann RH,Murphy E,Mehta A,Hughes D,Neubauer S,Elliott PM,Moon JC (2013) The Identification and Assessment of Anderson Fabry Disease by Cardiovascular Magnetic Resonance Non-Contrast Myocardial T1 Mapping. Circ Cardiovasc Imaging. 10.1161/CIRCIMAGING.112.000070.
  4. O'Mahony C,Tome-Esteban M,Lambiase PD,Pantazis A,Dickie S,McKenna WJ,Elliott PM (2013) A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy Heart, 99(8), 534 - 541.
  5. Coats CJ,Gallagher MJ,Foley M,O'Mahony C,Critoph C,Gimeno J,Dawnay A,McKenna WJ,Elliott PM (2013) Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. Eur Heart J. 10.1093/eurheartj/eht070.
  6. Rapezzi C,Arbustini E,Caforio AL,Charron P,Gimeno-Blanes J,Heliö T,Linhart A,Mogensen J,Pinto Y,Ristic A,Seggewiss H,Sinagra G,Tavazzi L,Elliott PM (2013) Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J, 34(19), 1448 - 1458. 10.1093/eurheartj/ehs397.
  7. O'Mahony C,Tome-Esteban M,Lambiase PD,Pantazis A,Dickie S,McKenna WJ,Elliott PM (2013) A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. Heart, 99(8), 534 - 541. 10.1136/heartjnl-2012-303271.
  8. Gossios TD,Lopes LR,Elliott PM (2013) Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1. Eur J Med Genet. 10.1016/j.ejmg.2013.03.001.
  9. Lopes LR,Elliott PM (2013) New approaches to the clinical diagnosis of inherited heart muscle disease. Heart. 10.1136/heartjnl-2012-301995.
  10. Lopes LR,Elliott PM (2013) Genetics of heart failure. Biochim Biophys Acta. 10.1016/j.bbadis.2012.12.012.
  11. Coats CJ,Parisi V,Ramos M,Janagarajan K,O'Mahony C,Dawnay A,Lachmann RH,Murphy E,Mehta A,Hughes D,Elliott PM (2013) Role of serum N-terminal pro-brain natriuretic peptide measurement in diagnosis of cardiac involvement in patients with anderson-fabry disease American Journal of Cardiology, 111(1), 111 - 117.
  12. Lopes LR,Zekavati A,Syrris P,Hubank M,Giambartolomei C,Dalageorgou C,Jenkins S,McKenna W,Uk10k Consortium ,Plagnol V,Elliott PM (2013) Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet, 50(4), 228 - 239. 10.1136/jmedgenet-2012-101270.
  13. Pasquale F,Syrris P,Kaski JP,Mogensen J,McKenna WJ,Elliott P (2012) Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene Circulation. Cardiovascular Genetics, 5(1), 10 - 17.
  14. Elliott P,McKenna WJ (2012) Diseases of the Myocardium and Endocardium.
  15. Coats CJ,Paresi V,Ramos M,Janagarajan K,O'Mahony C,Dawnay A,Mehta A,Hughes D,Elliott PM (2012) Role of serum NT-proBNP measurement in the diagnosis of early cardiac involvement in patients with anderson-fabry disease EUROPEAN HEART JOURNAL, 33, 861 - 861.
  16. Coats CJ,Patel A,Mist B,Tome M,Dickie S,McKenna WJ,Elliott PM (2012) Sub-maximal exercise parameters are important prognostic markers in hypertrophic cardiomyopathy EUROPEAN HEART JOURNAL, 33, 288 - 288.
  17. O'Mahony C,Tome-Esteban M,Pantazis A,Dickie S,McKenna W,Elliott P (2012) Validation of the 2003 ACC/ESC guidelines on the risk stratification of sudden cardiac death in hypertrophic cardiomyopathy EUROPEAN HEART JOURNAL, 33, 195 - 195.
  18. O'Mahony C,Rahman S,Biagini E,Rappezzi C,Monseratt L,Gimeno JR,Limongelli G,Anastasakis A,McKenna W,Elliott P (2012) A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy: a proof of concept study EUROPEAN HEART JOURNAL, 33, 364 - 364.
  19. Lopes LR,Syrris P,Hubank M,Giambartolomei C,Zekavati A,Dalageorgou C,Jenkins S,Plagnol V,Elliott PM (2012) New genetic determinants of disease phenotype in hypertrophic cardiomyopathy: high-throughput sequencing reveals unexpected complexicity EUROPEAN HEART JOURNAL, 33, 860 - 860.
  20. Narula N,Favalli V,Tarantino P,Grasso M,Pilotto A,Bellazzi R,Serio A,Gambarin FI,Charron P,Meder B,Pinto Y,Elliott PM,Mogensen J,Bolognesi M,Bollati M,Arbustini E (2012) Quantitative Expression of the Mutated Lamin A/C Gene in Patients With Cardiolaminopathy Journal of the American College of Cardiology.
  21. Coats CJ,Parisi V,Ramos M,Janagarajan K,O'Mahony C,Dawnay A,Lachmann RH,Murphy E,Mehta A,Hughes D,Elliott PM (2012) Role of Serum N-Terminal Pro-Brain Natriuretic Peptide Measurement in Diagnosis of Cardiac Involvement in Patients With Anderson-Fabry Disease American Journal of Cardiology.
  22. Quarta G,Elliott PM (2012) Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy REVISTA ESPANOLA DE CARDIOLOGIA, 65(7), 599 - 605. 10.1016/j.rec.2012.02.015.
  23. Quarta G,Elliott PM (2012) Diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy | Criterios diagnósticos para la miocardiopatía arritmogénica del ventrículo derecho Revista Espanola de Cardiologia, 65(7), 599 - 605.
  24. Sado DM,Flett AS,Banypersad SM,White SK,Maestrini V,Quarta G,Lachmann RH,Murphy E,Mehta A,Hughes DA,McKenna WJ,Taylor AM,Hausenloy DJ,Hawkins PN,Elliott PM,Moon JC (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart, 98(19), 1436 - 1441. 10.1136/heartjnl-2012-302346.
  25. Pacileo G,Salerno G,Gravino R,Calabrò R,Elliott PM (2012) Risk stratification in hypertrophic cardiomyopathy: time for renewal? J Cardiovasc Med (Hagerstown). 10.2459/JCM.0b013e328357739e.
  26. Patel V,Elliott P (2012) Sudden death in athletes CLINICAL MEDICINE, 12(3), 253 - 256.
  27. Coats C,Elliott P (2012) The collapsing pulse. Br J Hosp Med (Lond), 73(5), C78 - C80.
  28. Quarta G,Elliott PM (2012) Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy | Criterios diagnósticos para la miocardiopatía arritmogénica del ventrículo derecho Revista Espanola de Cardiologia.
  29. Andersen PS,Hedley PL,Page SP,Syrris P,Moolman-Smook JC,McKenna WJ,Elliott PM,Christiansen M (2012) A novel myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity Biochemistry Research International.
  30. Quarta G,Elliott PM (2012) Diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy. Rev Esp Cardiol (Engl Ed), 65(7), 599 - 605. 10.1016/j.recesp.2012.02.016.
  31. Hughes DA,Malmenäs M,Deegan PB,Elliott PM,Ginsberg L,Hajioff D,Ioannidis AS,Orteu CH,Ramaswami U,West M,Pastores GM,Jenkinson C (2012) Fabry international prognostic index: A predictive severity score for Anderson-Fabry disease Journal of Medical Genetics, 49(3), 212 - 220.
  32. Lambiase PD,Nunn LM,Bhar-Amato J,Lowe MD,Macfarlane PW,Rogers P,McKenna WJ,Elliott PM (2012) Reply. J Am Coll Cardiol, 59(18), 1660 - 1661. 10.1016/j.jacc.2012.01.031.
  33. Matthews E,Plotz PH,Portaro S,Parton M,Elliott P,Humbel RL,Holton JL,Keegan BM,Hanna MG (2012) A case of necrotizing myopathy with proximal weakness and cardiomyopathy. Neurology, 78(19), 1527 - 1532. 10.1212/WNL.0b013e3182553baa.
  34. Kaski JP,Syrris P,Shaw A,Alapi KZ,Cordeddu V,Esteban MT,Jenkins S,Ashworth M,Hammond P,Tartaglia M,McKenna WJ,Elliott PM (2012) Prevalence of sequence variants in the RAS-mitogen activated protein kinase signaling pathway in pre-adolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet, 5(3), 317 - 326. 10.1161/CIRCGENETICS.111.960468.
  35. Lopes L,Syrris P,Hubank M,Giambartolomei C,Zekavati A,Dalageorgou C,Jenkins S,Plagnol V,Elliott P (2012) GENETIC COMPLEXITY IN HYPERTROPHIC CARDIOMYOPATHY: PRELIMINARY FINDINGS WITH NEXT GENERATION SEQUENCING JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 59(13), E1578 - E1578.
  36. Page SP,Kounas S,Syrris P,Christiansen M,Frank-Hansen R,Andersen PS,Elliott PM,McKenna WJ (2012) Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet, 5(2), 156 - 166. 10.1161/CIRCGENETICS.111.960831.
  37. Elliott PM,Mohiddin SA (2012) European NSJ Almanac 2011: Cardiomyopathies. Arch Cardiol Mex, 82(1), 59 - 65.
  38. Sado D,Flett A,White SK,Banypersad SM,Maestrini V,Mehta A,Hawkins PN,Hausenloy DJ,Elliott P,Moon J (2012) Interstitial expansion in health and disease - an equilibrium contrast CMR study. J Cardiovasc Magn Reson, 14 Suppl 1, O23. 10.1186/1532-429X-14-S1-O23.
  39. Hughes DA,Malmenäs M,Deegan PB,Elliott PM,Ginsberg L,Hajioff D,Ioannidis AS,Orteu CH,Ramaswami U,West M,Pastores GM,Jenkinson C,FOS Investigators (2012) Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease. J Med Genet, 49(3), 212 - 220. 10.1136/jmedgenet-2011-100407.
  40. O'Mahony C,Lambiase PD,Quarta G,Cardona M,Calcagnino M,Tsovolas K,Al-Shaikh S,Rahman SM,Arnous S,Jones S,McKenna W,Elliott P (2012) The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy Heart, 98(2), 116 - 125.
  41. Quarta G,Syrris P,Ashworth M,Jenkins S,Zuborne Alapi K,Morgan J,Muir A,Pantazis A,McKenna WJ,Elliott PM (2012) Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J, 33(9), 1128 - 1136. 10.1093/eurheartj/ehr451.
  42. O'Mahony C,Lambiase PD,Rahman SM,Cardona M,Calcagnino M,Quarta G,Tsovolas K,Al-Shaikh S,McKenna W,Elliott P (2012) The relation of ventricular arrhythmia electrophysiological characteristics to cardiac phenotype and circadian patterns in hypertrophic cardiomyopathy. Europace, 14(5), 724 - 733. 10.1093/europace/eur362.
  43. Wicks EC,Elliott PM (2012) Genetics and metabolic cardiomyopathies. Herz, 37(6), 598 - 610. 10.1007/s00059-012-3659-0.
  44. van Rijsingen IA,Arbustini E,Elliott PM,Mogensen J,Hermans-van Ast JF,van der Kooi AJ,van Tintelen JP,van den Berg MP,Pilotto A,Pasotti M,Jenkins S,Rowland C,Aslam U,Wilde AA,Perrot A,Pankuweit S,Zwinderman AH,Charron P,Pinto PM (2012) Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study Journal of the American College of Cardiology, 59(5), 493 - 500.
  45. Elliott PM,Mohiddin SA (2012) Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology. Turk Kardiyol Dern Ars, 40(1), 76 - 84.
  46. Elliott PM,Mohiddin SA (2012) Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology. Rev Port Cardiol, 31(3), 255 - 261. 10.1016/j.repc.2012.01.012.
  47. Narula N,Favalli V,Tarantino P,Grasso M,Pilotto A,Bellazzi R,Serio A,Gambarin FI,Charron P,Meder B,Pinto Y,Elliott PM,Mogensen J,Bolognesi M,Bollati M,Arbustini E (2012) Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy Journal of the American College of Cardiology, 60(19), 1916 - 1920.
  48. Garcia-Pavia P,Syrris P,Salas C,Evans A,Mirelis JG,Cobo-Marcos M,Vilches C,Bornstein B,Segovia J,Alonso-Pulpon L,Elliott PM (2011) Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study. HEART, 97(21), 1744 - 1752. 10.1136/hrt.2011.227967.
  49. O'Mahony C,Coats C,Cardona M,Garcia A,Calcagnino M,Murphy E,Lachmann R,Mehta A,Hughes D,Elliott PM (2011) Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace. 10.1093/europace/eur267.
  50. Quarta G,Muir A,Pantazis A,Syrris P,Gehmlich K,Garcia-Pavia P,Ward D,Sen-Chowdhry S,Elliott PM,McKenna WJ (2011) Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: Impact of genetics and revised task force criteria Circulation, 123(23), 2701 - 2709.

There are no biographical details to display

Keywords

  • Cardiovascular
  • Clinical Research
  • Clinical trials
  • Epidemiology
  • Fabry
  • Genetic screens
  • Genetics
  • Genomic analyses
  • Genomics
  • Heart disease
  • Mitochondria
  • Ultrasound diagnosis